Peer-influenced content. Sources you trust. No registration required. This is HCN.
Specialty Pharmacy Continuum
As pharmacists, it’s crucial to note that, although these changes in FDA guidelines may not directly impact your practice, they signify a shift in how biosimilars will be identified moving forward. This could potentially influence how you advise patients about these products.
Clinical Pharmacology October 30th 2023
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH